A team of Chinese researchers has found that clot-dissolving medication – alteplase – can be key to improving stroke patients' recovery by more than 50 per cent. 

The team from Zhejiang University, presenting the research at the American Stroke Association's recent International Stroke Conference 2025, held in Los Angeles, US, reported that the medicine is effective when given up to 24 hours after the beginning of an ischemic stroke.